PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea flag South Korea · Delayed Price · Currency is KRW
325,250
+250 (0.08%)
Apr 29, 2026, 11:40 AM KST

PharmaResearch Market Cap

PharmaResearch has a market cap or net worth of 3.38 trillion as of April 28, 2026. Its market cap has decreased by -7.01% in one year.

Market Cap
3.38T
Enterprise Value
3.01T
Revenue
536.29B
Ranking
n/a
PE Ratio
21.76
Stock Price
325,250.00

Market Cap Chart

Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.38T, an increase of 234.57%. That is a compound annual growth rate of 11.87%.

History

DateMarket Cap% Change
Apr 28, 20263,376.64B-19.35%
Dec 30, 20254,187.03B53.52%
Dec 30, 20242,727.28B144.17%
Dec 28, 20231,116.95B60.18%
Dec 29, 2022697.32B-14.76%
Dec 30, 2021818.02B48.15%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
SK bioscience 3,436.40B
D&D Pharmatech 3,583.18B
Hugel 2,867.74B
OliX Pharmaceuticals 3,989.06B
Voronoi 5,507.62B
Orum Therapeutics 1,942.76B
Peptron 6,307.34B
Chabiotech 1,621.51B
Market Cap Rankings